James Riddle, Vice President, Research Services & Strategic Consulting Columbia, MD (Private) Virtual Presentation  Advarra advances the way cell and gene therapy clinical research is conducted: bringing life sciences companies, CROs, research sites, investigators, and academia together at the intersection of safety, technology, and collaboration. With trusted institutional review...

Gregory Banik, Ph.D., Vice President, Operations Exton, PA (Private) Virtual Presentation  CellPort Software is a software-as-a-service company founded with the goal of doing away with paper lab notebooks and digitalizing cell-related data and workflows to bring about the digital transformation of cell and gene therapy. CellPort’s vision is to...

Alexander Vos, CEO Amsterdam, Netherlands (Private) Virtual Presentation VectorY Therapeutics is combining the power of gene therapy technology and antibodies to develop new therapies for neurodegenerative and muscle diseases. Founded in October 2020, and based in the Amsterdam Science Park, VectorY is a fully integrated gene therapy company focused...

Tania Pereira Chilima, Ph.D., Chief Technology Officer Nivelles, Belgium (Private) Virtual Presentation  Univercells Technologies is a global provider of innovative biomanufacturing technologies to achieve cost-effective viral production from R&D to commercial scales. The company offers a comprehensive technology portfolio leveraging the strengths of process intensification and chaining as a...

Karen Kozarsky, Ph.D., Chief Science Officer Bala Cynwyd, PA (Private) Virtual Presentation SwanBio Therapeutics is the premier, CNS spinal cord-focused, AAV gene therapy company that pioneers new approaches to bring life-changing treatments to people with devastating, genetically defined neurological conditions. www.swanbiotx.com...

Seth Taylor, Ph.D., Chief Business Officer Boston, MA (Private) Virtual Presentation SmartLabs is a transformative new flexible lab infrastructure platform for R&D. We are revolutionizing the way life-changing therapies and technologies are brought to market by providing cutting-edge lab infrastructure that allows biopharma clients to run their own research...

Pavan Cheruvu, M.D., CEO New York City, NY (NASDAQ: SIOX) Virtual Presentation Sio Gene Therapies combines cutting-edge science with bold imagination to develop genetic medicines that aim to radically improve the lives of patients. Our current pipeline of clinical-stage candidates includes the first potentially curative AAV-based gene therapies for...

Gil Carrasquinho, M.D., Vice President Head of Cell Therapy Osaka, Japan (OTCMKTS: SNPHY) Virtual Presentation Santen Pharmaceutical is one of the world’s leading specialist ophthalmic pharmaceutical companies, founded in Japan over a century ago and now serving patients all over the world. We’re the ophthalmology market leader in Japan....

Bijan Nejadnik, M.D., Chief Medical Officer and Head of Research Mountain View, CA (TSE: 4592) Virtual Presentation SanBio is engaged in the regenerative cell medicine business, spanning research, development, manufacture, and sales of regenerative cell medicines. The company’s propriety regenerative cell medicine product, SB623, is currently being investigated for...

Matt Drew, Vice President, Sales and Marketing Frederick, MD (Private) Virtual Presentation At RoosterBio, we are pioneers in radically simplifying the use of adult human mesenchymal stem/stromal cells to propel the commercialization of regenerative technologies. By enabling living cells to become more affordable at the lowest cost per million...

By using this website you agree to accept our Privacy Policy and Terms & Conditions